Similar articles for PMID: 15111472

Year	Number of Results
1996	1
1999	2
2000	1
2001	1
2002	2
2003	3
2004	13
2005	20
2006	9
2007	7
2008	6
2009	8
2010	4
2011	3
2012	2
2013	2
2015	1
2016	1
2018	1
2020	1
2021	2
2022	1
2024	0

1

Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials.

Wooltorton E. Wooltorton E. CMAJ. 2004 Apr 27;170(9):1395. doi: 10.1503/cmaj.1040539. CMAJ. 2004. PMID: 15111472 Free PMC article. No abstract available.

2

Weight changes during treatment with olanzapine in older adult patients with dementia and behavioral disturbances.

Lipkovich I, Ahl J, Nichols R, Hardy T, Poole Hoffmann V. Lipkovich I, et al. J Geriatr Psychiatry Neurol. 2007 Jun;20(2):107-14. doi: 10.1177/0891988706298629. J Geriatr Psychiatry Neurol. 2007. PMID: 17548781

3

Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.

Layton D, Harris S, Wilton LV, Shakir SA. Layton D, et al. J Psychopharmacol. 2005 Sep;19(5):473-82. doi: 10.1177/0269881105056524. J Psychopharmacol. 2005. PMID: 16166184

4

A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia.

Kryzhanovskaya LA, Jeste DV, Young CA, Polzer JP, Roddy TE, Jansen JF, Carlson JL, Cavazzoni PA. Kryzhanovskaya LA, et al. J Clin Psychiatry. 2006 Jun;67(6):933-45. doi: 10.4088/jcp.v67n0610. J Clin Psychiatry. 2006. PMID: 16848653

5

Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics.

Liperoti R, Gambassi G, Lapane KL, Chiang C, Pedone C, Mor V, Bernabei R. Liperoti R, et al. J Clin Psychiatry. 2005 Sep;66(9):1090-6. doi: 10.4088/jcp.v66n0901. J Clin Psychiatry. 2005. PMID: 16187764

6

Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.

Marder SR, Sorsaburu S, Dunayevich E, Karagianis JL, Dawe IC, Falk DM, Dellva MA, Carlson JL, Cavazzoni PA, Baker RW. Marder SR, et al. J Clin Psychiatry. 2010 Apr;71(4):433-41. doi: 10.4088/JCP.08m04411gry. Epub 2010 Feb 9. J Clin Psychiatry. 2010. PMID: 20156413

7

Agitation and psychosis in dementia.

Ballard C. Ballard C. Am J Geriatr Psychiatry. 2007 Nov;15(11):913-7. doi: 10.1097/JGP.0b013e3181584268. Am J Geriatr Psychiatry. 2007. PMID: 17974863 No abstract available.

8

Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.

Finkel S, Kozma C, Long S, Greenspan A, Mahmoud R, Baser O, Engelhart L. Finkel S, et al. Int Psychogeriatr. 2005 Dec;17(4):617-29. doi: 10.1017/S1041610205002280. Epub 2005 Oct 5. Int Psychogeriatr. 2005. PMID: 16202186

9

Olanzapine-associated myoclonus.

Rosen JB, Milstein MJ, Haut SR. Rosen JB, et al. Epilepsy Res. 2012 Feb;98(2-3):247-50. doi: 10.1016/j.eplepsyres.2011.07.020. Epub 2011 Dec 21. Epilepsy Res. 2012. PMID: 22196307

10

[Olanzapine induced rhabdomyolysis and serum creatine kinase increase].

Ribeyron S, Guy C, Koenig M, Cathébras P. Ribeyron S, et al. Rev Med Interne. 2009 Jun;30(6):477-85. doi: 10.1016/j.revmed.2008.12.024. Rev Med Interne. 2009. PMID: 19307047 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

87 results

Results by year